1. Home
  2. VYGR vs NREF Comparison

VYGR vs NREF Comparison

Compare VYGR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$13.07

Market Cap

244.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
NREF
Founded
2013
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
244.2M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
NREF
Price
$3.76
$13.07
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$21.00
$14.50
AVG Volume (30 Days)
837.1K
48.1K
Earning Date
03-09-2026
04-30-2026
Dividend Yield
N/A
15.24%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
N/A
Revenue This Year
$54.19
$24.65
Revenue Next Year
$20.22
N/A
P/E Ratio
N/A
$4.78
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$12.14
52 Week High
$5.55
$16.80

Technical Indicators

Market Signals
Indicator
VYGR
NREF
Relative Strength Index (RSI) 43.57 29.18
Support Level $3.60 $12.36
Resistance Level $4.43 $15.25
Average True Range (ATR) 0.33 0.44
MACD -0.03 -0.18
Stochastic Oscillator 4.37 3.97

Price Performance

Historical Comparison
VYGR
NREF

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: